EXPERIMENTAL ANTITUMOR-ACTIVITY OF 5'-NOR-ANHYDROVINBLASTINE NAVELBINE

被引：31

作者：

MARAL, R

BOURUT, C

CHENU, E

MATHE, G

机构：

来源：

CANCER LETTERS | 1984年 / 22卷 / 01期

关键词：

D O I：

10.1016/0304-3835(84)90042-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：49 / 54

页数：6

共 9 条

[1]

BRADE WP, 1981, P INT VINCA ALKALOID, P95

[2] PHASE I ANTI-CANCER AGENTS - VINDESINE (DESACETYL VINBLASTINE AMIDE SULFATE) [J].

DYKE, RW ;

NELSON, RL .

CANCER TREATMENT REVIEWS, 1977, 4 (02) :135-142

[3]

HAYAT M, 1979, CANCER CHEMOTH PHARM, V3, P217

[4] 5'-NOR ANHYDROVINBLASTINE - PROTOTYPE OF A NEW CLASS OF VINBLASTINE DERIVATIVES [J].

MANGENEY, P ;

ANDRIAMIALISOA, RZ ;

LALLEMAND, JY ;

LANGLOIS, N ;

LANGLOIS, Y ;

POTIER, P .

TETRAHEDRON, 1979, 35 (18) :2175-2179

[5] NEW CLASS OF ANTI-TUMOR COMPOUNDS - 5'-NOR AND 5',6'-SECO DERIVATIVES OF VINBLASTINE-TYPE ALKALOIDS [J].

MANGENEY, P ;

ANDRIAMIALISOA, RZ ;

LANGLOIS, N ;

LANGLOIS, Y ;

POTIER, P .

JOURNAL OF ORGANIC CHEMISTRY, 1979, 44 (22) :3765-3768

[6] EXPERIMENTAL INVIVO CROSS-RESISTANCE OF VINCA ALKALOID DRUGS [J].

MARAL, R ;

BOURUT, C ;

CHENU, E ;

MATHE, G .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 5 (03) :197-199

[7]

MARAL R, 1983, CURRENT DRUGS METHOD, P189

[8]

RAHMANI R, 1982, MED ONCOL, V8, P45

[9]

WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269

← 1 →